Skip to main content
. 2022 Nov 19;16(1):4–14. doi: 10.1016/j.jiph.2022.11.024

Fig. 1.

Fig. 1

Mutations of spike protein amino acids of Omicron variant of SARS-CoV-2 causing in higher infectivity (by strengthening the binding with host ACE2 receptors) and reduced neutralization by antibodies (mAb, T-cell, or convalescent plasma). These changes of biological characteristics encourage higher transmissibility of the virus infecting both people with and without antibodies.